Else Nutrition Receives Patent For Formulation Composition Of Infant And Toddler Formula
Else Nutrition Holdings (CSE: BABY) this morning put out a brief release, indicating that the firm has secured a Canadian patent for its infant and toddler food formulation composition for use in a non-dairy formula. The Canadian patent effectively serves as a follow-up to the patent portfolio already held by the company.
The patent, Registration No.: 2,898,980, reportedly provides the composition of the proteins, amino-acids and other nutrients needed in a single food serving for a whole balanced nutrition. The granting of the patent follows a worldwide patent already held by the company that covers its plant-based formulations.
The firm has stated that it remains focused on the launch of their products, however, the patent will provide further opportunity for the $3.0 billion plant-based food market in Canada.
Else Nutrition last traded at $3.64 on the CSE.
Information for this briefing was found via Sedar and Else Nutrition. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
